Mutual Recognition (South Australia) (Controlled Substances) Regulations 2015

The instrument rests on three principal legal concepts and a short list of operational features. The concepts are: (1) declaration of goods, (2) declaration of laws, and (3) time‑limited exemptions.

1. Declaration of goods. Each of regulations 4(1)(a), 5(1)(a) and 6(1)(a) declares specified substances, and any preparation containing one or more of those substances, to be “goods to which section 15 of the Commonwealth Act applies.” The Schedule and the list in regulation 6(3) provide the chemical names and alternative names that the instrument treats as the objects of that declaration. The phrase “any preparation containing 1 or more of those substances” is sufficiently broad to capture mixtures, formulations, or products where a listed substance is an ingredient (see regs 4(1)(a), 5(1)(a), 6(1)(a)).

2. Declaration of laws. Parallel to declaring goods, each declaration regimen also declares that particular provisions of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 are “a law to which section 15 of the Commonwealth Act applies” (regs 4(1)(b), 5(1)(b), 6(1)(b)). The instrument expressly ties the declared provisions to the provisions as inserted by specified variation regulations (for example, the 2015 Variation Regulations and the 2017 Miscellaneous Variation Regulations). The regulations therefore do not create new offences or substance schedules themselves; instead they nominate parts of an existing subordinate instrument as the laws to which the Commonwealth section applies.

3. Time‑limited exemptions. Each category of declaration is set to have effect for 12 months after the regulation’s commencement (regs 4(2), 5(2), 6(2)). The text repeats this 12‑month limit for each separate declaration stream, making temporality a core design feature.

Operationally, the instrument is a schedule‑driven instrument. Schedule 1 lists multiple named synthetic substances with multiple synonyms and trade names; regulation 6 provides an additional, separate list that includes fentanyl analogues, benzodiazepine analogues and other named compounds. The legislative history shows that the instrument is modular: new categories were added to this instrument by later variations (see legislative history entries for 245/2015 and 306/2017, and the notes to the provisions that those variations inserted). The regulations do not specify procedural requirements, licensing, recording obligations, penalties, or agency responsibilities; they effect declarations of connection between particular goods/laws and section 15 of the Commonwealth Act. Because the instrument repeatedly invokes “for the purposes of section 5 of the Act and section 15 of the Commonwealth Act” (regs 4(1), 5(1), 6(1)), its operation depends on the substantive content and mechanics of those external provisions, which are not reproduced in this instrument.

Additional drafting features: Schedule 1 contains long chemical names, alternative names and acronyms (for example AB-001, STS-135, 5F-AKB48, 25H‑NBOMe, NM2201, alpha‑PVP etc). Regulation 6(3)(e) and (f) include open‑text class descriptions , “N,N‑Dialkylaminocyclohexyl alkyl benzamides (not otherwise listed in Schedule 1 …)” and “N,N‑Dialkylaminocyclohexylmethyl alkyl benzamides (not otherwise listed in Schedule 1 …)” , which create cross‑references between the lists in the regulations and Schedule 1 of the Controlled Substances Regulations 2014. The instrument therefore relies on cross‑referencing across instruments and schedules rather than providing a standalone schedule of all controlled substances.

Finally, the instrument includes a statutory short title (reg 1) and a brief interpretation provision defining “Act” as “the Mutual Recognition (South Australia) Act 1993” (reg 3). The legislative history explains the procedural history and records subsequent variation instruments and revocations.

The regulations themselves do not name individual private persons, agencies, or classes of commercial enterprises; they operate by changing the statutory status of named substances and particular provisions of an existing controlled‑substances instrument. From that mechanism one can identify who must take account of the instrument’s effects.

Primary private parties affected. Any person or business that manufactures, imports, supplies, sells, transports, stores, or otherwise deals with the substances named in Schedule 1 or in regulation 6(3), or with preparations containing one or more of those substances, will be within the ambit of the instrument’s declarations because regs 4(1)(a), 5(1)(a) and 6(1)(a) expressly bring those substances and preparations within the class of “goods to which section 15 of the Commonwealth Act applies.” The text does not detail what commercial activities are permitted or prohibited; practitioners handling those substances will need to consult the Act and the Commonwealth Act to determine legal entitlements or restrictions that flow from the declarations.

Regulatory and enforcement authorities. The instrument declares particular provisions of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 to be “a law to which section 15 of the Commonwealth Act applies” (regs 4(1)(b), 5(1)(b), 6(1)(b)). Agencies that administer, enforce, or regulate under the Controlled Substances Regulations , and agencies that apply the Mutual Recognition (South Australia) Act 1993 , must therefore take the declarations into account. The instrument identifies which provisions are in play by reference to the variation instruments that inserted them; this will require regulators to consult both the Controlled Substances Regulations 2014 and the specified variation regulations to establish the precise regulatory text that the declaration references.

Intermediaries and service providers. Lawyers, customs brokers, chemical suppliers, laboratories, occupational health and safety officers, postal and freight carriers, and wholesalers who deal with packaging or transport of listed substances will need to assess how the declaration of those substances as goods subject to section 15 affects permitting, import/export paperwork, labelling, testing and interactions with Commonwealth and state regulatory regimes. The regulations’ broad phrase “any preparation containing 1 or more of those substances” (regs 4(1)(a), 5(1)(a), 6(1)(a)) means formulations, dilutions, tinctures, and other mixed products may be captured, increasing the number of potentially affected suppliers and intermediaries.

Legal advisers and compliance professionals. Because the instrument does not spell out the substantive consequences of the declarations, legal advisers, compliance officers and in‑house counsel will be required to consult the Mutual Recognition (South Australia) Act 1993 and the referenced Commonwealth Act (section 15) to determine rights, obligations and potential exposures arising from the declarations. The legislative history shows that the instrument has been varied (regs 5 and 6 inserted by later variations), so those advisers must track amendments and expiry dates (see legislative history entries for 245/2015 and 306/2017).

Absence of explicit beneficiaries or victims in the text. The regulations neither list persons who benefit from the declarations nor identify persons who are subject to enforcement action. They operate by altering the statutory relationship between named substances, particular provisions of the Controlled Substances Regulations 2014, and section 15 of the Commonwealth Act. Consequently, identifying affected parties requires reading this instrument together with the Mutual Recognition (South Australia) Act 1993 and the Commonwealth Act referenced in the regulations.

Temporal audience. Because each declaration lasts only 12 months (regs 4(2), 5(2), 6(2)), the scope of who is affected can shift rapidly: those operating in ongoing commercial lines that touch these substances will need to monitor expiry dates and legislative variations to maintain compliance and business continuity.

The regulations are primarily declaratory and temporal; they do not themselves set out granular duties, penalties, licensing regimes or specific rights. Instead they specify which goods and which provisions of an existing controlled‑substances instrument are to be treated as matters “to which section 15 of the Commonwealth Act applies” (regs 4(1), 5(1), 6(1)). Consequently, the duties and rights that matter in practice are those established by the mutual recognition framework and the referenced Commonwealth Act and Controlled Substances Regulations. The instrument signals which external statutory texts will govern, but it does not reproduce or modify the operative duties or rights in those texts.

Rights that are referenced but not defined here. By declaring goods and laws to be within the ambit of section 15 of the Commonwealth Act (regs 4(1), 5(1), 6(1)), the regulations confer whatever rights that Commonwealth section provides on persons dealing with the declared goods or subject to the declared laws. The regulations do not specify those rights; the user must consult section 15 of the Commonwealth Act and section 5 of the Mutual Recognition (South Australia) Act 1993 for the operative legal effects. The mandate in the regulations is therefore directional: it points to the external provisions as the source of rights.

Duties that are referenced but not created here. Similarly, any duties, compliance obligations or prohibitions that arise in respect of the declared goods or declared laws stem from the Controlled Substances Regulations 2014 and the Commonwealth Act provisions referenced. The regulations do not create new criminal offences, licensing obligations, reporting requirements, record‑keeping duties, or administration regimes themselves. They declare a statutory relationship; the substance and enforcement of duties remain in the external instruments.

Temporal constraints on rights and duties. Each declaration is expressly limited to a 12‑month period from commencement (regs 4(2), 5(2), 6(2)). That temporal limit affects the persistence of any rights conferred or duties modified by the declaration. If a right or relief depends on the instrument’s declaration that a substance is a “good to which section 15 applies,” that entitlement will cease at the expiry of the 12 months unless the regulation is remade, extended, or the underlying Commonwealth or state provisions are changed. Practitioners should therefore treat any rights or duties claimed under these temporary declarations as time‑bounded.

Cross‑references and non‑exhaustive listings. Regulation 6(3)(e) and (f) use cross‑referencing language , “not otherwise listed in Schedule 1 of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014” , which means duties and rights may depend on the interplay between this instrument’s lists and Schedule 1 of the Controlled Substances Regulations 2014. In other words, the precise set of substances to which duties or rights attach may require checking multiple instruments and schedules.

No administrative processes, no express compliance steps. The regulations do not establish an administrative pathway to exercise rights or meet duties (for example, there is no application form, notification requirement, or registration step included in this instrument). Any operational processes will derive from the mutual recognition framework and the Controlled Substances Regulations 2014 and their variations which are referenced but not reproduced.

Practical consequence. The key practical implication is that this instrument directs readers to external statutory provisions as the source of their duties and rights with respect to the listed substances; it does not itself impose operational obligations nor does it specify enforcement mechanisms. The 12‑month temporality and the explicit cross‑references mean duties and rights are contingent on time and on the text of the instruments cited in regs 4(1)(b), 5(1)(b) and 6(1)(b).

The regulations do not create penalties, prescribe enforcement mechanisms, or set inspection or administrative regimes. They are declaratory: they nominate substances and particular provisions of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 as matters to which section 15 of the Commonwealth Act applies (regs 4(1), 5(1), 6(1)). Any penalties or enforcement consequences for conduct involving the listed substances will therefore arise, if at all, from the Commonwealth Act and the Controlled Substances Regulations 2014 (including the variation regulations that inserted the provisions the instrument references). The text of this instrument does not reproduce or amend penalty provisions.

What the instrument records about enforcement sources. Each of regs 4(1)(b), 5(1)(b) and 6(1)(b) declares particular provisions of the Controlled Substances Regulations 2014 to be “a law to which section 15 of the Commonwealth Act applies.” Because the declared “laws” are parts of the Controlled Substances Regulations 2014, enforcement powers, penalties, and administrative sanctions that exist in, or are authorised by, those regulations remain the operative enforcement architecture. The Mutual Recognition (South Australia) (Controlled Substances) Regulations 2015 do not themselves state enforcement powers or penalty amounts.

Practical implication for enforcement bodies and regulated entities. Enforcement bodies will need to determine the content of the declared provisions by consulting the Controlled Substances Regulations 2014 and the variation regulations cited in this instrument. The legislative history identifies which variation regulations inserted the relevant provisions (for example, the Controlled Substances (Controlled Drugs, Precursors and Plants) Variation Regulations 2015 and the Controlled Substances (Controlled Drugs, Precursors and Plants) (Miscellaneous) Variation Regulations 2017), so enforcement agencies and regulated entities must consider those instruments in combination with this regulation to establish the applicable offences, defences, or sanctions.

Absence of new investigatory powers. The instrument does not create new search, seizure, or investigatory powers, nor does it change licensing thresholds, on its face. If any change in enforcement practice occurs as a consequence of these declarations, it will be because the declared substances become subject to the enforcement regime of the declared law or because of the interplay of section 15 of the Commonwealth Act with the Controlled Substances Regulations 2014; the Mutual Recognition (South Australia) (Controlled Substances) Regulations 2015 do not themselves authorise or condition the exercise of enforcement powers.

Temporal enforcement window. Because each of the declarations is temporary (12 months: regs 4(2), 5(2), 6(2)), any enforcement consequences that depend on the declaration being in force will be constrained to that temporal window. After expiry, the declared connection between the substances and section 15 will lapse unless extended. Agencies and regulated entities should not assume permanence from these declarations; enforcement exposure may change at expiry.

Advice point. Practical enforcement analysis therefore requires reading this instrument together with the Mutual Recognition (South Australia) Act 1993, the Commonwealth Act (section 15, as referenced), the Controlled Substances Regulations 2014, and the variation instruments cited in regs 4(1)(b), 5(1)(b) and 6(1)(b). The penalties and enforcement consequences that apply to persons handling the listed substances are those contained in those other instruments, not in this regulation itself.

This instrument operates entirely by cross‑reference to other statutory texts; its legal effects are therefore interactional rather than self-contained. The regulations repeatedly frame their declarations “for the purposes of section 5 of the Act and section 15 of the Commonwealth Act” (see regs 4(1), 5(1), 6(1)). Consequently the way in which these regulations change legal positions depends on the substantive provisions of those external sections and of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 and their variation instruments.

Direct cross‑references. The instrument expressly declares that specified provisions of the Controlled Substances Regulations 2014 , in particular, the provisions inserted by the Controlled Substances (Controlled Drugs, Precursors and Plants) Variation Regulations 2015 (reg 4(1)(b)) and those inserted by the Controlled Substances (Controlled Drugs, Precursors and Plants) (Miscellaneous) Variation Regulations 2017 (reg 6(1)(b)) , are “a law to which section 15 of the Commonwealth Act applies.” Those explicit citations force readers to consult both the base Controlled Substances Regulations 2014 and the specified variation instruments in order to know which laws are declared and what their text is.

Dependence on the Mutual Recognition framework. The regulations invoke the Mutual Recognition (South Australia) Act 1993 (the Act) via the defined term “Act” (reg 3) and the repeated reference to “section 5 of the Act.” The instrument therefore presumes the operation of the mutual recognition framework set out in the Act and in the referenced Commonwealth Act. The regulation itself does not recite the mutual recognition rules; rather it identifies the specific goods and subordinate‑legislation provisions to which section 15 of the Commonwealth Act should be taken to apply. To understand the legal consequences, a practitioner must read the Mutual Recognition (South Australia) Act 1993 and the relevant Commonwealth Act provisions in parallel with these regulations.

Cross‑instrument dependencies and potential gaps. Several provisions in regulation 6 reference classes of substances by excluding those “otherwise listed in Schedule 1 of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014” (reg 6(3)(e)-(f)). That drafting creates an interactional dependency where the universe of captured substances is determined by comparing this instrument’s lists with Schedule 1 of the Controlled Substances Regulations 2014. Practitioners therefore need to reconcile lists across instruments to determine whether a given compound is caught and which legal rules apply.

Temporal interaction. The instrument’s 12‑month expiry periods (regs 4(2), 5(2), 6(2)) mean the interactional legal landscape will change at expiry unless further legislative action is taken. Any mutual recognition effect, any adjustment to controlled‑substances regulatory coverage, or any change in enforcement approach that depends on this instrument will endure only for the stated 12 months unless re‑enacted or embedded elsewhere.

Legislative history as interaction evidence. The legislative history records the revocation of earlier Mutual Recognition (South Australia) Regulations 2013 by the principal 2015 regulations, and it records subsequent variations that inserted regs 5 and 6 (see entries for 245/2015 and 306/2017). Those entries demonstrate that the instrument has been used as a channel for adding new declarations over time rather than as a static, once‑only listing; this creates an interactional pattern where the instrument functions as a vehicle for updating the mutual recognition status of specific controlled substances in response to changes effected by other subordinate instruments.

Notes and caution about references. The instrument carries an editorial note that references in legislation to other instruments or office titles may not be automatically updated and therefore may be obsolete. That caution underscores the need to check the current text of the Controlled Substances Regulations 2014 and the variation instruments referenced in regs 4(1)(b), 5(1)(b), 6(1)(b) to ensure the practitioner is relying on the correct, current cross‑referenced materials.

In sum, the instrument’s legal effect is derivative: it alters which external statutory texts apply to particular substances for the purposes of a mutual recognition provision, but understanding the substantive legal outcome requires reading and reconciling multiple instruments , the Mutual Recognition (South Australia) Act 1993, the referenced Commonwealth Act (section 15), the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014, and the variation regulations identified in the instrument.

The instrument is concise but its legislative history shows it has been used as a dynamic vehicle to add new declarations over time. The legislative history in the text identifies the principal regulations and two later variation instruments that inserted new provisions. Below is a chronological, text‑grounded account.

Principal instrument and commencement. The Mutual Recognition (South Australia) (Controlled Substances) Regulations 2015 were made as principal regulations in 2015. The legislative history records an entry: 2015 No. 189, Gazette 23.7.2015 p3551, with commencement noted as 23.7.2015: r 2 (Legislative history table). That entry reflects the principal regulation number and the date associated with the instrument’s initial commencement.

Variation of the instrument , December 2015. Regulation 5 was inserted by variation 245/2015: the legislative history lists 2015 No. 245, Gazette 3.12.2015 p5165, with commencement recorded as 3.12.2015: r 2 and the note that r 5 was inserted by 245/2015 r 4 (Provisions varied table). The chronological entry at the head of the legislative history lists 2015 245 Gaz 3.12.2015 p5165 with commencement 3.12.2015 r 2. The variation added regulation 5, the separate temporary exemption that deals with MDMB-CHMICA (see reg 5 insertion note).

Omission of r 2 and Sch 2 under revision. The legislative history notes that r 2 and Sch 2 were omitted under the Legislation Revision and Publication Act 2002 on 3.12.2015 (Provisions varied table). Those omissions are editorial revision actions recorded in the history; they do not affect the substantive declarations contained in regs 4-6, but they do show that the published text has been subject to revision processes.

Variation of the instrument , November 2017. Regulation 6 was inserted by variation 306/2017: the legislative history records 2017 No. 306, Gazette 7.11.2017 p4551, with commencement 12.11.2017: r 2 and a note in the Provisions varied table that r 6 was inserted by 306/2017 r 4. That variation added the list of substances in reg 6(3) and the associated declaration machinery for those substances.

Revocation of earlier instrument. The legislative history records that the Mutual Recognition (South Australia) (Controlled Substances) Regulations 2015 revoked the Mutual Recognition (South Australia) Regulations 2013 (Legislation revoked by principal regulations). That indicates the 2015 instrument replaced the earlier 2013 regulations.

Historical versions noted. The legislative history lists a historical version date of 3.12.2015. This reflects the state of the instrument at that date, after the December 2015 variation. The presence of multiple dated entries in the legislative history indicates that there are distinct historical texts to consult if one needs to know the instrument’s content at a particular historical point.

Summary. The document’s recorded amendment history consists of:

• Principal regulations: 2015 No. 189 (commenced 23.7.2015).
• Variation 245/2015 (inserted reg 5, commenced 3.12.2015).
• Variation 306/2017 (inserted reg 6, commenced 12.11.2017).
• Omission of certain publishing provisions under the Legislation Revision and Publication Act 2002 on 3.12.2015.
• Revocation of the Mutual Recognition (South Australia) Regulations 2013 on commencement of the 2015 instrument.

Practitioners should note these amendment entries because the instrument is modular: new declarations were added by later variations rather than by a single consolidated enactment. Any reliance on the instrument therefore requires confirmation of the current consolidated text and attention to the insertion‑and‑expiry mechanics, since each declaration is temporary (12 months) and additions have been made by variation instruments.

The instrument as supplied contains no litigation history entries. The printed legislative text and the legislative history do not record any court decisions, statutory appeals, or judicial interpretations that arise under the Mutual Recognition (South Australia) (Controlled Substances) Regulations 2015. There are no cases named, no annotated decisions cited, and no reported judicial determinations linked in the legislative history text provided.

What this means for practitioners. Because the instrument is declaratory and succinct, and because the provided text contains no judicial material, any legal interpretation questions about the effect of these regulations will have to be resolved by reference to the applicable provisions of the Mutual Recognition (South Australia) Act 1993 and the Commonwealth Act (section 15), and to the text of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 and the variation regulations cited in regs 4(1)(b), 5(1)(b), and 6(1)(b). If litigation were to arise about whether the regulation validly declared substances to be goods to which section 15 applies, or about the scope or duration of those declarations, the courts’ treatment of any such disputes will be determined by the interplay between the Act, the Commonwealth Act, and the Controlled Substances Regulations rather than by the mutual recognition regulations alone.

Absence of precedent entries. The absence of litigation entries in the legislative history means there is no statutory record here of contested interpretations of the instrument’s temporal limits, the meaning of “preparation containing 1 or more of those substances,” or the interactional questions that arise where the instrument references “not otherwise listed in Schedule 1” of the Controlled Substances Regulations 2014. In practice, those are likely to be the kinds of issues that would generate disputes if parties sought to rely on the declarations in commercial, regulatory, or enforcement contexts.

Practical note. For any dispute or compliance question, the starting point is therefore the primary legislation and the external Commonwealth Act and Controlled Substances Regulations cited in the instrument. The instrument’s own text should be treated as a procedural connector; litigation would focus on the operation of the underlying laws to which this instrument directs readers.

The instrument’s concise drafting and reliance on cross‑references generate a number of practical traps and points of potential misinterpretation. These are matters a practitioner should verify before advising clients or relying on the regulation.

Time‑limited effect. Each of the declarations in regs 4-6 has effect for only 12 months from commencement (regs 4(2), 5(2), 6(2)). A party that changes its commercial arrangements on the assumption that the declaration is permanent risks losing that status at expiry. This temporal feature is repeated in each regulation and is therefore not conditional on other facts. Verify commencement and expiry dates and whether the relevant 12‑month window has been extended or replaced by further legislative action.

Reliance on external provisions not reproduced here. The regulations repeatedly refer to “section 15 of the Commonwealth Act” and to “section 5 of the Act” (regs 4(1), 5(1), 6(1)). The operational consequences of these declarations depend entirely on the content of those external sections. The instrument does not state what rights, defences, or exemptions section 15 provides. Do not infer substantive legal effects from this instrument alone; consult the referenced Commonwealth Act provision and the Mutual Recognition (South Australia) Act 1993.

Broad capture through “preparations.” The phrase “any preparation containing 1 or more of those substances” appears in regs 4(1)(a), 5(1)(a), 6(1)(a). That broad language may capture complex formulations, minor contaminants, or low‑concentration mixtures. A product containing trace amounts of a listed substance could fall within the declaration; careful chemical characterisation and legal analysis are needed.

Cross‑instrument “not otherwise listed” language. Regulation 6(3)(e) and (f) use exclusionary cross‑references to Schedule 1 of the Controlled Substances Regulations 2014. That drafting means identification of whether a compound is caught requires checking more than one instrument and comparing lists. Misreading the “not otherwise listed” phrasing could lead to erroneous conclusions about whether a substance is within or outside the declared class.

Synonyms, acronyms, and alternative names. Schedule 1 lists many substances with synonyms and acronyms (for example AB‑CHMINACA, AB‑PINACA, AB‑FUBINACA, 5‑MeO‑DALT, 25H‑NBOMe, 4‑MEC, alpha‑PVP). A practitioner relying on a common or trade name without cross‑checking the chemical or systematic name may miss a capture. Chemical naming conventions vary, and Schedule 1 contains multiple naming styles; check all relevant synonyms and chemical identifiers.

Dependencies on variation instruments. The regulations declare as “a law to which section 15 … applies” specific provisions of the Controlled Substances Regulations 2014 as inserted by specified variation instruments (reg 4(1)(b), 5(1)(b), 6(1)(b)). Understanding what has been declared requires reading those variation regulations and the base Controlled Substances Regulations. Failure to inspect the variation instruments may cause one to miss the precise text of the declared law.

Editorial obsolescence warning. The instrument includes an editorial note that references to other legislation or office titles may not be automatically updated and therefore may be obsolete (Notes under Legislative history). Do not assume the cross‑references are current without confirming the up‑to‑date texts.

No procedural processes or licences specified here. The regulations do not specify how to claim any right or satisfy any condition that might flow from section 15 of the Commonwealth Act. If operational compliance requires applications, permits, or notices under another law, those processes will not be found in this instrument. Reliance solely on this instrument for procedural compliance is a gotcha.

Potential drafting gaps around enforcement. Because the regulations do not themselves create offences or penalties, a party could mistakenly assume that declaring a substance a “good to which section 15 applies” frees them from state-level obligations. Whether that is so depends on the external legal provisions; do not assume a declaration is equivalent to a licence or blanket permission to manufacture, supply, or import.

Expiry and successive variations. The instrument has been amended by insertion of regs 5 and 6 by later variations (see legislative history). That pattern suggests the instrument serves as a rolling vehicle for temporary declarations. Parties should not assume stability; regulatory status can change through further variations or lapse at expiry.

Checklist of high‑risk assumptions to avoid:

• Assuming the instrument itself prescribes the practical legal effects or enforcement consequences.
• Treating a 12‑month declaration as permanent.
• Missing that “preparation” language can capture mixtures and formulations.
• Failing to reconcile the instrument’s lists with Schedule 1 of the Controlled Substances Regulations 2014 and the cited variation instruments.
• Using colloquial or trade names without checking Schedule 1 for synonyms.

In short, the main practical gotchas are temporal limits, multi‑instrument cross‑references, broad capturing language for preparations, synonym and naming complexity in Schedule 1, and the absence of procedural or penalty details in the instrument itself. Always cross‑check the Controlled Substances Regulations 2014, the variation instruments identified in regs 4(1)(b), 5(1)(b), 6(1)(b), the Mutual Recognition (South Australia) Act 1993 and the referenced Commonwealth Act section 15 before concluding legal positions.

Because the regulations are declaratory and time‑limited, compliance requires a small number of confirmatory and monitoring steps rather than immediate application or licensing processes set out in this instrument. The following practical checklist flows directly from the text and the instrument’s mechanics.

1. Identify the relevant declared substance list. Consult Schedule 1 (for the substances named there) and regulation 6(3) (for the separate list of substances such as acetyl fentanyl, fentanyls, U‑47700, clonazolam, pyrazolam, and others). The instrument explicitly links those lists to the declarations (reg 4(1)(a) and reg 6(3)). Map your product or inventory against those names and synonyms. Pay attention to alternative names and acronyms enumerated in Schedule 1.

2. Determine whether your product is a “preparation containing 1 or more of those substances.” The regulations declare “any preparation containing 1 or more of those substances” to be goods to which section 15 applies (regs 4(1)(a), 5(1)(a), 6(1)(a)). If a product contains even a single listed substance, it falls within the declaration. Obtain analytical chemistry or formulation documentation to establish composition and concentrations.

3. Consult the Mutual Recognition (South Australia) Act 1993 and the referenced Commonwealth Act, specifically section 15. The regulations explicitly rely on those provisions (“for the purposes of section 5 of the Act and section 15 of the Commonwealth Act”) and do not themselves state the legal consequences or procedures (regs 4(1), 5(1), 6(1)). This step is essential to determine whether the declaration confers an entitlement, an exemption, or a regime that affects licensing, interstate supply, or enforcement.

4. Read the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 and the variation regulations cited. The instrument declares particular provisions of the Controlled Substances Regulations 2014 , specifically those inserted by the 2015 Variation Regulations and the 2017 Miscellaneous Variation Regulations , to be “a law to which section 15 of the Commonwealth Act applies” (regs 4(1)(b), 5(1)(b), 6(1)(b)). To know what is declared and the substantive obligations or offences involved, consult the base Regulations together with the variation instruments that are referenced.

5. Track expiry dates and variations. Each declaration operates for 12 months from commencement (regs 4(2), 5(2), 6(2)). Confirm the commencement date for the relevant declaration stream (see legislative history entries for the principal regulations and variations) and calendar the expiry. If your operations depend on the declaration, build contingencies for its expiry or for the possibility it may be re‑enacted, replaced, or varied.

6. Reconcile cross‑references. If regulation 6 uses exclusionary language referencing Schedule 1 of the Controlled Substances Regulations 2014 (reg 6(3)(e)-(f)), reconcile the lists across the instruments to determine capture. Check whether a substance is “otherwise listed” in Schedule 1 of the Controlled Substances Regulations 2014 before concluding it is excluded.

7. Maintain documentation and labelling. Because the instrument has broad capture wording for preparations, maintain up‑to‑date compositional documentation, certificates of analysis, labelling data sheets and supplier declarations that prove the presence or absence of listed substances. That documentation will be essential should regulators query whether a product falls within the declared class.

8. Coordinate with regulators and enforcement agencies. The regulations do not set out notification, permit, or licensing procedures. If your operations involve listed substances, proactively engage the relevant regulatory authority to clarify whether any procedural steps are required under the Mutual Recognition (South Australia) Act 1993, the Commonwealth Act, or the Controlled Substances Regulations 2014.

9. Seek legal advice for interstate supply issues. Because the instrument operates in the context of mutual recognition and because it is declaratory vis‑à‑vis section 15 of a Commonwealth Act, getting tailored legal advice on the cross‑jurisdictional implications is important. The regulations do not contain procedural instructions or remedies; legal advice will be required to interpret the interplay of the statutes in specific commercial scenarios.

10. Monitor for legislative variations and editorial updates. The legislative history shows that regs 5 and 6 were inserted by later variations (245/2015 and 306/2017). Also note the instrument’s editorial note warning that references may be obsolete. Subscribe to official consolidation services or check the relevant government legislation website for up‑to‑date consolidated texts, variation instruments and commencement notices.

Practical example checklist for an affected supplier:

• Step 1: Compare product chemical composition against Schedule 1 and reg 6(3).
• Step 2: If matched, obtain or prepare a certificate of analysis showing concentrations.
• Step 3: Consult section 15 of the Commonwealth Act and the Mutual Recognition (South Australia) Act 1993 to determine legal implications for interstate sale or supply.
• Step 4: Check the Controlled Substances Regulations 2014 and the specific variation instruments cited in regs 4(1)(b), 5(1)(b) or 6(1)(b) to identify any specific offences or licensing obligations.
• Step 5: Calendar the 12‑month expiry date and set review reminders well before expiry to avoid inadvertent non‑compliance after the declaration lapses.
• Step 6: If in doubt, obtain written regulatory guidance or a legal opinion to record the compliance position.

The regulations therefore require confirmatory legal and factual steps rather than proscriptive compliance actions located within the instrument itself. Compliance is achieved by mapping the declared substances and declared laws against the external statutory regimes that the instrument points to (the Mutual Recognition (South Australia) Act 1993, the Commonwealth Act s15, and the Controlled Substances Regulations 2014 and their variations), and by implementing practical product testing, documentation and monitoring processes tied to the instrument’s 12‑month temporal design.